The business of clinical trials is booming. Private equity has taken notice.

3D render of a medical background with DNA strands

After finding success investing in the more obviously lucrative corners of American medicine — like surgery centers and dermatology practices — private equity firms have moved aggressively into the industry’s more hidden niches: They are pouring billions into the business of clinical drug trials.

‘Spoiler Alert’ review: Say hello to your new favorite 10-hankie tearjerker

Previous article

Tesla delivers first Semi electric truck to Pepsi

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News